FCS: All five major factories will release their production capacity next year
●Alan Wang, CEO of FCS Group (FCS).
Five years ago, FCS decided to establish a plant in India. Despite facing the impact of the COVID-19 pandemic, the company, through astute geopolitical management strategies, successfully navigated through the downturn. In 2022, the group achieved record-breaking overall revenue, and the Indian facility began turning a profit in the second quarter of 2023. Observing the global market positioning of "FCS," the next goal is to break into the top ten globally.
CEO Alan Wang stated that FCS, with a history of 49 years, has forged strong bonds between generations. The company has become Taiwan's leading manufacturer of plastic injection molding equipment through collaborative efforts. Alan Wang took over as CEO five years ago, with Chairman Po Hsun Wang's elder son, Jerry Wang, serving as Vice Chairman (also Chairman of FCS China Headquarters), and the younger son, Alan Wang, as CEO. Alan Wang, upon taking office, decided to establish the Indian factory, aiming to find the next growth curve for the group. The choice of India as the first production base outside Greater China was primarily due to optimism about the demographic dividend and the aspiration to tap into the next major market beyond China. Despite facing headwinds from COVID-19, the challenges were overcome, and the investment in the factory started showing a modest profit in Q2 2023, with future expectations to surpass the Taiwan facility.
Alan Wang highlighted that in the past, plastic injection molding mainly involved single-color injection. Since 2008, FCS has been a leader in planning and developing dual-color and multi-color injection molding machines. With the recent trend towards lightweight materials replacing steel and glass, multi-color machines have become FCS's main products. Currently, they have a high market share in China's automotive manufacturers and the world's top six automotive lamp manufacturers. Additionally, the company has already begun laying the groundwork for the next growth engine. As of 2025, the international shoemaking industry will prohibit the use of chemical foaming agents. FCS's developed physical foaming injection molding system, GENTREX, is poised to capture the market demand for machine replacement.
FCS already has two factories in China, in Ningbo and Dongguan. Among them, the Ningbo factory ranks fourth in local export earnings. With over half of the revenue coming from mainland China, it constitutes FCS's largest market. The new Hangzhou Bay factory is scheduled to open and commence production in 2024, coinciding with the 50th-anniversary celebration of "FCS," making it the grandest gift for the occasion in the Asia-Pacific region, with all five major factories operating at full capacity.
Source - Industrial and Commercial Times
